Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-01

Clinical Trial Update: The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating oral naloxone to prevent postoperative ileus after spinal fusion was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone (Naloxone)

Snippet

Sponsor: Loyola University | Conditions: Ileus, Fusion of Spine | Phase 4 | Status: TERMINATED | Results posted: 2024-07-01